NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
12 hedge funds and large institutions have $776K invested in NeuroMetrix, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.
4% less capital invested
Capital invested by funds: $812K → $776K (-$35.7K)
20% less funds holding
Funds holding: 15 → 12 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.75K |
| 2 |
Renaissance Technologies
New York
|
+$1.06K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$30K |
| 2 |
Morgan Stanley
New York
|
-$3.39K |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
-$1K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$26 |
NURO Hedge Fund Activity: Q1 2023 in Review
12 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q1 2023, worth a combined $776K — down 4.4% from $812K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NURO and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, opening a new position worth an estimated $6.75K. The largest seller was Millennium Management, exiting entirely with an estimated $30K sold.
- 12 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q1 2023, down from 15 in Q4 2022.
- Funds reported $776K of NeuroMetrix, Inc. Common Stock stock for Q1 2023, down 4.4% quarter-over-quarter.
- 1 fund opened new NeuroMetrix, Inc. Common Stock positions in Q1 2023 and 4 closed out, a net change of -3 holders.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q1 2023 was UBS Group, an estimated $6.75K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q1 2023 was Millennium Management, an estimated $30K sold.
Based on aggregated 13F filings for Q1 2023.